Cresco Labs cannabis cultivation employees in Massachusetts ditch union
Employees at a Cresco Labs cannabis cultivation facility in Fall River, Massachusetts, voted to de-unionize earlier this month.
Employees at a Cresco Labs cannabis cultivation facility in Fall River, Massachusetts, voted to de-unionize earlier this month.
Unionized workers at a Curaleaf Holdings marijuana store in Arizona remain without a contract despite a brief 4/20 protest on Saturday.
A long-delayed social equity fund intended to prop up small marijuana businesses in Massachusetts has launched.
A New Mexico congressman is pressing the U.S. Department of Homeland Security to account for what regulated marijuana operators claim is a rash of seizures of state-legal cannabis at Customs and Border Protection checkpoints.
The U.S. Drug Enforcement Administration will sign off on moving marijuana to Schedule 3 of the Controlled Substances Act, one federal lawmaker believes.
A protest is expected to greet customers visiting Curaleaf Holdings’ marijuana store on Camelback Road in Phoenix on Saturday – the 4/20 unofficial cannabis holiday and one of the busiest days of the year for retailers.
North Dakota voters could see a “consumer-friendly, yet highly regulated” recreational cannabis legalization proposal on their November ballots.
The latest Congressional leadership crisis means the Republican-controlled House of Representatives is “unlikely” to take up marijuana banking reform, a GOP senator believes.
Predatory investors hijacked the cannabis social equity program in Arizona, where only three of the original 26 license winners still have a stake in their businesses, according to allegations filed in court and repeated in the state Legislature.
Missouri marijuana retailers set another monthly sales record in March with $124.7 million in adult-use and medical cannabis transactions.
There’s “no reason” for the U.S. Drug Enforcement Administration to delay its long-awaited decision on moving marijuana from Schedule 1 to Schedule 3 of the Controlled Substances Act, the head of the Food and Drug Administration told a House committee.
Alabama medical marijuana licenses would be revoked and businesses forced to “start from scratch” and reapply for a fourth time under a bill that’s advanced out of a state Senate committee.